Article ; Online: U-shaped association of uric acid to overall-cause mortality and its impact on clinical management of hyperuricemia.
2022 Volume 51, Page(s) 102271
Abstract: Serum uric acid (SUA) is significantly elevated in obesity, gout, type 2 diabetes mellitus, and the metabolic syndrome and appears to contribute to the renal, cardiovascular and pulmonary comorbidities that are associated with these disorders. Most ... ...
Abstract | Serum uric acid (SUA) is significantly elevated in obesity, gout, type 2 diabetes mellitus, and the metabolic syndrome and appears to contribute to the renal, cardiovascular and pulmonary comorbidities that are associated with these disorders. Most previous studies have focused on the pathophysiologic effects of high levels of uric acid (hyperuricemia). More recently, research has also shifted to the impact of hypouricemia, with multiple studies showing the potentially damaging effects that can be caused by abnormally low levels of SUA. Along with these observations, recent inconclusive data from human studies evaluating the treatment of hyperuricemia with xanthine oxidoreductase (XOR) inhibitors have added to the debate about the causal role of UA in human disease processes. SUA, which is largely derived from hepatic degradation of purines, appears to exert both systemic pro-inflammatory effects that contribute to disease and protective antioxidant properties. XOR, which catalyzes the terminal two steps of purine degradation, is the major source of both reactive oxygen species (O2 |
---|---|
MeSH term(s) | Diabetes Mellitus, Type 2/drug therapy ; Enzyme Inhibitors ; Humans ; Hydrogen Peroxide ; Hyperuricemia/drug therapy ; Hyperuricemia/metabolism ; Uric Acid/metabolism |
Chemical Substances | Enzyme Inhibitors ; Uric Acid (268B43MJ25) ; Hydrogen Peroxide (BBX060AN9V) |
Language | English |
Publishing date | 2022-02-17 |
Publishing country | Netherlands |
Document type | Journal Article ; Review ; Research Support, U.S. Gov't, Non-P.H.S. ; Research Support, N.I.H., Extramural |
ZDB-ID | 2701011-9 |
ISSN | 2213-2317 ; 2213-2317 |
ISSN (online) | 2213-2317 |
ISSN | 2213-2317 |
DOI | 10.1016/j.redox.2022.102271 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.